other HCV Information

HISTORY OF HCV

GLOSSARY/ABBREVIATIONS

LIVER FUNCTIONS

QUESTIONS ABOUT HCV

EXTRAHEPATIC CONDITIONS

SYMPTOMS

TRANSMISSION

SEXUAL TRANSMISSION

HCV BLOOD TESTS/LABS

LABS ON TREATMENT

BIOPSY RESULTS

ALTERNATIVE TO BIOPSY

STILL NEED A BIOPSY ?

ON BIOPSY WHAT DOES THE STAGE MEAN AND WHAT DOES THE GRADE ME ?

STAGES/LIVER DISEASE

FIBROSIS

CIRRHOSIS

TRANSPLANTS

LIVER CANCER

GENOTYPES

VIRAL LOAD

PEGASYS/ PEGINTRON

INFERGEN

HELP/SIDE EFFECTS

DRUG INTERACTIONS

NUTRITION  & HCV

TREATMENT STORIES

FIRST SHOT

INTERVIEWS

FIND A DOCTOR

FINANCIAL AID/MED ETC

SUPPORT GROUPS/TRANSPLANTS

HCV SUPPORT GROUPS

PICTURES Of OUR FRIENDS

INFORMATIONAL LINKS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This Web Site is committed to the memory of Janis Morrow.

Human liver   

AASLD

( American Association for the Study of Liver Diseases 2001)

( Highlights of DDW 2002 )

NEWS ARCHIVES INDEX

              
Durability of Sustained Virologic response in patients with Chronic Hepatitis c after treatment With Interferon 2b Alone or in Combination with Ribavirin
Impact of Pegylated Interferon alfa-2b (Peg-Intron) and Ribavirin on Progression of Liver Fibrosis in patients with Chronic Hepatitis C
Abstract 676. ACUTE HEPATITIS C: NATURAL COURSE AND RESPONSE TO ANTIVIRAL TREATMENT
HALT-C Trial: 4-year study of Maintenance Therapy in 1350 patients
Pegylated interferon alfa/ribavirin in persons who failed to prior interferon based therapy
Hepatitis B Therapy at AASLD
HCV Viral Load Ultrasensitive Testing
How Often Should You Do a Liver Biopsy?
Interferon Improves Risk for Death and Cancer
New Hepatitis B Drugs
HCV Therapy in HCV/HIV Coinfection
OPEN-LABEL PHASE 1B STUDY OF HEPATITIS C VIRAL DYNAMICS WITH OMEGA INTERFERON TREATMENT
HCV Therapy Adherence; New drugs
EFFECT OF INTERFERON THERAPY ON THE RISK OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN PATIENTS WITH CHRONIC HEPATITIS C: A LARGE RETROSPECTIVE COHORT STUDY OF 3296 PATIENTS
Menopause May Accelerate Liver Fibrosis; Perhaps Hormone Replacement Therapy Can Be Helpful
SEN Virus Variants Are "Unequivocally Transmitted By Blood Transfusion" in the US
Treatment of Chronic Hepatitis C
New HCV Drug in Phase I
Idun Pharmaceuticals' Clinical Trial
Rivarin-High Dose Interferon Combination Improves Responses In Hepatitis C
Sweden Approves Expanded Use of Naturally-Derived Alpha Interferon
Phase II Trial of ISIS 14803 for Hepatitis C Getting Underway
 

On Page Two:

Research Articles 2002 & 2003 Always Updated

Page Three:

HCV  Highlights from DDW 2002  (New)

 

Page Four

 

Reports from Digestive Disease Week 2003: Orlando Fla, May 17-22

   
   
   
   
   

 

 


Design downloaded from Zeroweb.org: Free website templates, layouts, and tools.